Apply knowledge of recent clinical data together with current expert recommendations to patient selection for new and emerging therapies for advanced and triple negative breast cancer
Apply knowledge in the treatment of breast cancer ins special populations including the elderly and young women and adjust treatment decisions for specific patients as needed
Recognize the opportunities and limitations of genomic testing in the management of early- and late-stage breast cancer
Apply knowledge of recent clinical data together with current expert recommendations to patient selection for new and emerging therapies for advanced and triple negative breast cancer as well as in the treatment of breast cancer in special populations including the elderly young women and adjust treatment decisions for specific patients as needed
See course registration page for additional learning objectives
This is an accredited, livestreamed course offered by the Dana Farber/Brigham and Women's Cancer Center and the Massachusetts General Hospital Cancer Center. This course is targeted to Primary Care Physicians, Specialty Physicians, Nurses, Nurse Practitioners, and Physician Assistants. This course may also be of interest to physicians who practice in Family Medicine, Internal Medicine, Genetics, Oncology and Hematology, Plastic Surgery, Radiology, and Surgery.
Select the Take Course button to view additional information on the course registration page.
Contact ceprograms@hms.harvard.edu with questions.
*Register before June 15 to receive the discounted price.
